Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on March 5, 2009

Stroke. 2009
Published online before print March 5, 2009, doi: 10.1161/STROKEAHA.108.527911
A more recent version of this article appeared on April 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/4/1275    most recent
STROKEAHA.108.527911v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oddo, M.
Right arrow Articles by Le Roux, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oddo, M.
Right arrow Articles by Le Roux, P. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OXYGEN
Related Collections
Right arrow Energy metabolism
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

Submitted on June 4, 2008
Revised on July 3, 2008
Accepted on July 31, 2008

Hemoglobin Concentration and Cerebral Metabolism in Patients With Aneurysmal Subarachnoid Hemorrhage

Mauro Oddo MD; Andrew Milby BS; Isaac Chen MD; Suzanne Frangos RN; Eileen MacMurtrie MSN; Eileen Maloney-Wilensky MSN; Michael Stiefel MD; W. Andrew Kofke MD; Joshua M. Levine MD; and Peter D. Le Roux MD*

From the Departments of Neurosurgery (M.O., A.M., I.C., S.F., E.M., E.M.-W., M.S., W.A.K., J.M.L., P.D.L.), Neurology (J.M.L.), and Anesthesia and Critical Care (W.A.K., J.M.L.), University of Pennsylvania Medical Center, Philadelphia, Pa.

* To whom correspondence should be addressed. E-mail: Peter.LeRoux{at}uphs.upenn.edu.

Background and Purpose—The optimal hemoglobin (Hgb) target after aneurysmal subarachnoid hemorrhage is not precisely known. We sought to examine the threshold of Hgb concentration associated with an increased risk of cerebral metabolic dysfunction in patients with poor-grade subarachnoid hemorrhage.

Methods—Twenty consecutive patients with poor-grade subarachnoid hemorrhage who underwent multimodality neuromonitoring (intracranial pressure, brain tissue oxygen tension, cerebral microdialysis) were studied prospectively. Brain tissue oxygen tension and extracellular lactate/pyruvate ratio were used as markers of cerebral metabolic dysfunction and the relationship between Hgb concentrations and the incidence of brain hypoxia (defined by a brain tissue oxygen tension <20 mm Hg) and cell energy dysfunction (defined by a lactate/pyruvate ratio >40) was analyzed.

Results—Compared with higher Hgb concentrations, a Hgb concentration <9 g/dL was associated with lower brain tissue oxygen tension (27.2 [interquartile range, 21.2 to 33.1] versus 19.9 [interquartile range, 7.1 to 33.1] mm Hg, P=0.02), higher lactate/pyruvate ratio (29 [interquartile range, 25 to 38] versus 36 [interquartile range, 26 to 59], P=0.16), and an increased incidence of brain hypoxia (21% versus 52%, P<0.01) and cell energy dysfunction (23% versus 43%, P=0.03). On multivariable analysis, a Hgb concentration <9 g/dL was associated with a higher risk of brain hypoxia (OR, 7.92; 95% CI, 2.32 to 27.09; P<0.01) and cell energy dysfunction (OR, 4.24; 95% CI, 1.33 to 13.55; P=0.02) after adjusting for cerebral perfusion pressure, central venous pressure, PaO2/FIO2 ratio, and symptomatic vasospasm.

Conclusions—A Hgb concentration <9 g/dL is associated with an increased incidence of brain hypoxia and cell energy dysfunction in patients with poor-grade subarachnoid hemorrhage.


Key words: brain oxygen • cerebral microdialysis • hemoglobin • subarachnoid hemorrhage